# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-272284
Filing Date
2025-11-07
Accepted
2025-11-07 16:01:45
Documents
124
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | d908386d20f.htm iXBRL | 20-F | 3333962
2 | EX-4.22 | d908386dex422.htm | EX-4.22 | 109300
3 | EX-4.23 | d908386dex423.htm | EX-4.23 | 123958
4 | EX-12.1 | d908386dex121.htm | EX-12.1 | 10431
5 | EX-12.2 | d908386dex122.htm | EX-12.2 | 10383
6 | EX-13.1 | d908386dex131.htm | EX-13.1 | 6003
7 | EX-15.1 | d908386dex151.htm | EX-15.1 | 3681
9 | GRAPHIC | g908386g1107173505030.jpg | GRAPHIC | 2153
| Complete submission text file | 0001193125-25-272284.txt |  | 15110069

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | kzia-20250630.xsd | EX-101.SCH | 2118449
127 | EXTRACTED XBRL INSTANCE DOCUMENT | d908386d20f_htm.xml | XML | 3354242

Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 251462476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)